WE ARE GATEHOUSE BIO
Leveraging small RNA to develop novel, transformational therapies
- AI-powered sRNA drug discovery platform identifies drug targets and stratifies patients with common molecular profiles
- sRNA-signatures are a new class of therapeutics with sRNA focused mechanisms of action
- Growing ecosystem of partnerships establishes a foundation for building an accelerated and scalable pipeline
We are leading the charge in AI-powered sRNA drug development
Opportunities
abound
Explore how the future of precision therapy begins with sRNA technology.
Opportunities
unleashed
Take a deep dive into our AI-powered platform for advanced drug discovery.
Opportunities
accessed
Contact us to collaborate, partner, and develop with our team.
